BamSEC and AlphaSense Join Forces
Learn More

Palvella Therapeutics Inc.

NASDAQ: PVLA    
Share price (1/8/25): $14.25    
Market cap (1/8/25): $18.8 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.11
from 8-K 4 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.10
from 8-K 1 page Articles of Incorporation or Bylaws
12/34/56
EX-3.9
from 8-K 3 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.2
from 425 2 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.2
from 8-K 2 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 4 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 425 4 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 425 4 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 4 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 1 page Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 15 pages Certificate of Designation of Series E Convertible Preferred Stock of Pieris Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 15 pages Certificate of Designation of Series D Convertible Preferred Stock of Pieris Pharmaceuticals, Inc
12/34/56
EX-3.2
from 10-Q 25 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 10-Q 13 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 13 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 2 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K ~10 pages Pieris Pharmaceuticals, Inc. Attachment to Certificate of Designation Certificate of Designation of Series B Convertible Preferred Stock of Pieris Pharmaceuticals, Inc
12/34/56
EX-3.1
from 10-Q 16 pages /S/ Darlene Deptula-Hicks Signature of Officer Filing Fee: $175.00 Important: Failure to Include Any of the Above Information and Submit With the Proper Fees May Cause This Filing to Be Rejected. This Form Must Be Accompanied by Appropriate Fees. See Attachment. Nevada Secretary of State Stock Designation Revised: 1-5-15
12/34/56
EX-3.1
from 8-K 15 pages Pieris Pharmaceuticals, Inc. Attachment to Certificate of Designation Certificate of Designation of Series a Convertible Preferred Stock of Pieris Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 24 pages Pieris Pharmaceuticals, Inc. Amended and Restated Bylaws
12/34/56